- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD) in Canada
Total 3699 results
-
PfizerTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Canada, United Kingdom, Poland, Netherlands
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveSouth Africa, United States, Canada, Ukraine, United Kingdom, Denmark, Czechia
-
SunovionCompletedChronic Obstructive Pulmonary Disease | Emphysema | BronchitisUnited States
-
AstraZenecaMenarini GroupCompletedPulmonary Disease, Chronic ObstructiveGermany, Hungary, Spain, Canada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Canada, Germany, Poland, Romania, Spain, United States, Korea, Republic of, Netherlands
-
University of British ColumbiaWithdrawnPulmonary Disease, Chronic ObstructiveCanada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Czech Republic, Denmark, Finland, Germany, South Africa, Spain, United Kingdom
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Sweden, Australia, Hungary, Bulgaria, South Africa, Poland, Slovakia, India, Canada, Argentina, Czech Republic, Chile, New Zealand, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineParexelCompletedPulmonary Disease, Chronic ObstructivePoland, United States, Russian Federation
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Russian Federation, Ukraine, United States, South Africa, Korea, Republic of, Romania, Canada, France, Italy, Chile, Denmark
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Hungary, Taiwan, South Africa, Germany, Bulgaria, Japan, Sweden, Poland, Slovakia, Argentina, Canada, Czech Republic, Spain
-
McMaster UniversitySt. Joseph's Healthcare HamiltonRecruitingBronchiectasis | Chronic Obstructive Pulmonary Disease | Asthma | Emphysema | Pulmonary Fibrosis | Alpha 1-Antitrypsin Deficiency | Bronchopulmonary Dysplasia | Sarcoidosis, PulmonaryCanada
-
Janssen Research & Development, LLCCompletedPulmonary Disease, Chronic Obstructive | AsthmaUnited States, France, United Kingdom, Germany, Canada, Netherlands, Romania, Denmark
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada, Germany, Netherlands, Sweden
-
Universidad de GranadaNot yet recruitingPulmonary Disease, Chronic ObstructiveSpain
-
GlaxoSmithKlineTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Argentina, France, Germany, Poland, Romania, Russian Federation, Spain, United States, Netherlands, Sweden, Korea, Republic of, Canada, United Kingdom, Italy, Mexico
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Chile, Romania, Canada
-
University of CalgaryActive, not recruitingHypertension | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Ischemic Heart Disease | Congestive Heart FailureCanada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Canada, Germany, Spain, United States, Italy, Netherlands, South Africa, Sweden, France, Mexico, Australia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, France, Greece, Korea, Republic of, New Zealand, Poland, Russian Federation, South Africa, Taiwan, Turkey, Ukraine, United Kingdom
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Netherlands, Portugal, Ukraine, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveCanada, United States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructivePuerto Rico, United States, Australia, Argentina, France, Germany, Japan, Netherlands, Russian Federation, Spain, Ukraine, Finland, Czechia, Poland, Belgium, Chile, Peru, South Africa, Sweden, Thailand, Israel, Korea, Republic of, C... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, France, Romania, Finland, Taiwan, Bulgaria, Estonia, Canada, Netherlands, Philippines, South Africa, Sweden, Spain, Singapore, Austria, Germany, Latvia, New Zealand, China, Ukraine, Thailand, Greece, United Kingdom and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Belgium, Canada, Germany, Russian Federation
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveArgentina, Brazil, Canada, Croatia, Czech Republic, Denmark, Finland, Germany, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Norway, Philippines, South Africa, Spain, Sweden, Thailand, Ukraine
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Romania, Russian Federation, Spain, Bulgaria, Canada, Hungary, Argentina
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Austria, Canada, Germany, Greece, New Zealand, Norway, Slovakia, South Africa, Sweden
-
Oregon Health and Science UniversityUniversity of Colorado, Denver; University of Iowa; University of Wisconsin,... and other collaboratorsActive, not recruitingCardiovascular Diseases | Cancer | Chronic Obstructive Pulmonary Disease | Frail Elderly Syndrome | Cerebrovascular Accident | Congestive Heart FailureUnited States, Canada
-
University of CalgaryUniversity of AlbertaActive, not recruitingHypertension | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Ischemic Heart Disease | Congestive Heart FailureCanada
-
University of CalgaryAlberta Innovates Health Solutions; Canadian Diabetes AssociationActive, not recruitingHypertension | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Ischemic Heart Disease | Congestive Heart FailureCanada
-
University of CalgaryUniversity of AlbertaActive, not recruitingHypertension | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Ischemic Heart Disease | Congestive Heart FailureCanada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveArgentina, Brazil, Canada, Czech Republic, Denmark, Finland, Germany, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Norway, Philippines, Romania, Russian Federation, South Africa, Spain, Sweden, Thailand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
University of WaterlooYMCA; Royal Bank of CanadaCompletedObesity | Diabetes | Chronic Obstructive Pulmonary Disease | Fibromyalgia | Osteoporosis | High Blood Pressure | Osteo Arthritis | Joint Replacement | Stable Heart ConditionsCanada
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireTerminatedChronic Obstructive Pulmonary Disease | Alpha1-antitrypsin DeficiencyUnited States, Canada, Australia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, Austria, Canada, France, Germany
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Romania, Bulgaria, Argentina, Canada, Chile, Philippines, South Africa, Thailand, Netherlands, Korea, Republic of, Hungary, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
PfizerTerminatedDiabetes Mellitus | Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Brazil, Costa Rica, Germany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, Finland, France, Germany, Guatemala, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian... and more
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaboratorsTerminatedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
Novartis PharmaceuticalsCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Canada, Hungary, Japan, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Russian Federation, Chile, Poland, Mexico, Estonia, Korea, Republic of, Philippines
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Argentina, Germany, Spain, South Africa, Mexico, Peru, Netherlands, Canada, United Kingdom, Denmark, Chile, Italy, Sweden
-
McGill UniversityLaval University; Mount Sinai Hospital, MontrealUnknownPulmonary Disease, Chronic ObstructiveCanada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada